Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Submitted by
admin
on December 31, 2013 - 11:42am
Source:
Fierce Biotech
News Tags:
Argos
IPOs
Dendreon
AGS-003
personalized medicine
renal cell carcinoma
Headline:
Argos swings for a $60M IPO in the shadow of Dendreon's struggles
Do Not Allow Advertisers to Use My Personal information
